Canadian non-profit TheraPsil has announced that patients and medical professionals from across Canada will be reaching out to Parliamentarians to raise awareness of the medical benefits...
Colorado has voted to pass the Natural Medicine Health Act (Proposition 122) by 51.4%, which will see the decriminalisation and regulation of the use of psychedelic medicines.
Will Alberta’s new regulatory framework for the delivery of psychedelic therapies pave the way for their integration into the healthcare system, or will it create a...
On November 8, 2022, Colorado citizens will be casting their vote on the Natural Medicine Health Act 2022 which proposes to decriminalise and regulate the use...
In a groundbreaking move for Canada’s regulatory developments around psychedelics, Alberta has announced it will be introducing quality standards into its Mental Health Services Protection Act...
Psychedelic Health speaks to the founder of the Psychedelic Access and Research European Alliance (PAREA), Tadeusz Hawrot, about how the organisation aims to facilitate discussions around...
The Psychedelic Society’s event Action for change: Drug Policy Symposium will be providing an opportunity for audiences to learn from experts in the UK.
Backed by three top psychiatrists, 161 cluster headache sufferers in the UK have written an open letter to Home Office ministers Savid Javid and Kit Malthouse...
Last week Italy’s Constitutional Court blocked the country’s campaign calling for the decriminalisation of psychotropic substance cultivation.
A subcommittee of the Oregon Psilocybin Advisory Board (OPAB) is considering whether to provide special protections for religious practises involving the use of psilocybin.